The pharmaceutical industry has long been a highly profitable industry, showing steady growth with attractive yields. However, there has been increased pressure on the industry in recent years. Although profit margins for blockbuster drugs are still high, overall earnings are under enormous pressure due to many factors including regulatory and compliance issues, research and development expenses and the length of time it takes for drug approvals and licenses to be granted.
However, with the explosion of the emerging markets comes a regrettable side effect in that a significant percentage of people who are adopting westernised lifestyles will unfortunately acquire westernised illnesses. Already, China is experiencing a surge in diabetes cases and other such health-related issues. This, in turn, will benefit the drugs companies who will be well placed to treat the burgeoning numbers of patients.
These markets will safeguard the well-being of the larger companies but smaller operations could benefit too from investment into these locations. TGS has member firms in these emerging markets with industry-specific expertise and all are well placed to assist clients wishing to obtain new networking resources and professional assistance.
Our Sectors and Service
Howlader Maria & Co joins TGS Global Network
Howlader Maria & Co., Chartered Accountants is a professional firm in Bangladesh which is being formed to provi
Experience Provider joins TGS Global Network
Experience Provider M.E. Limited, is one of the top public accounting and tax advisory services firms in Jordan. They ar
Quantum Auditors & 123 Consulting joins TGS Global Network
TGS are proud to be in South Africa with our most recent member, Quantum Auditors / 1.2.3. Consulting. With offices situ
Massie Turcotte joins TGS Global Network
TGS are proud to announce a new member in Canada. Massie Turcotte gives TGS a presence that stands out from other
PGK Consultores joins TGS Global Network
TGS is delighted to announce the membership of PGK Consultores, Argentina. PGK is a dynamic firm whose partners began th